Neurology

Are antiplatelets and anticoagulants safe and beneficial in people with cavernomas?

Long-term antithrombotic therapy and risk of intracranial haemorrhage from cerebral cavernous malformations: a population-based cohort study, systematic review, and meta-analysis. Zuurbier SM, Hickman CR, Tolias CS, et al; Scottish Audit of Intracranial Vascular Malformations Steering Committee. Lancet Neurol 2019; 18:935-941. Abstract BACKGROUND: Antithrombotic (anticoagulant or antiplatelet) therapy is withheld from some patients with cerebral cavernous […]

via Are antiplatelets and anticoagulants safe and beneficial in people with cavernomas? — Neurochecklists Blog

Source link




Related posts

Author response: Pearls & Oy-sters: Challenging diagnosis of Gerstmann-Stra&x0308;ussler-Scheinker disease: Clinical and imaging findings

Newsemia

Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD

Newsemia

Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy